Public choices / October 2026

Rethinking restricted plants and fungi

What should adults be free to grow, possess or use, and which safeguards belong around medicine, commerce and public health? Different plants and fungi deserve specific arguments.

Twinkle / policy room

Connected Twinkles

Twinkle 46 / Brainstorming scenario

Restricted plants: proportionate rules and bounded adult choice

Develop substance-specific adult-autonomy reforms rather than treating every plant or fungus as the same problem. Separate non-commercial personal cultivation, regulated supply and supervised treatment.

Personal cultivation, commercial supply and prescribed treatment are different activities. Source-linked review could help develop proportionate rules for a specific substance rather than a blanket argument about all plants.

Explore the connected work

How it could work

  1. A public review identifies the conduct to change and the evidence of harm for each substance, with affected adults and health expertise involved.
  2. Draft a bounded personal-use pathway where justified, specifying age, third-party protections, storage, supply restrictions and enforcement.
  3. Evaluate impacts and revise rules where harms or exclusion emerge, while keeping medicinal product standards separate.

Everyday example

An adult can see the proposed rule for a particular plant and the safeguards, rather than being told that a medicine pathway already permits home growing.

Who could act and how it could be funded

States and the Commonwealth control different relevant rules; each draft needs jurisdiction-specific review. Cost implementation and evaluation alongside possible changes to enforcement burden.

Fair-go safeguards

This is a reform proposal, not permission under current law. No growing instructions. Protect children and third parties, avoid exaggerated benefit claims and do not let compliance costs recreate exclusion.

What would show progress

Enforcement burden; access; health and third-party harms; equity; autonomy; unintended effects.

Full room: ideas, tools and sources

Delivery roles: Australia's three levels of government · Victoria's parliamentary responsibilities.

What we can check

Personal use does not automatically exempt tobacco cultivation from licensing. ACT cannabis rules contain narrow exceptions to criminal liability and do not amount to national legalisation. Medical access to psilocybine or MDMA does not authorise personal cultivation or production. Each jurisdiction, substance and activity needs its own legal check; a reform proposal is not permission under current law.

Choices and tradeoffs

Reclassification and proportionate penaltiesReview whether existing categories and penalties fit the evidence of harm. Reduced penalties are different from legal supply, cultivation rights or medical approval.
Bounded adult personal-cultivation reformDebate a lawful non-commercial pathway with age, location, household and third-party protections. Autonomy and affordability gains must be weighed against access by children, product uncertainty and enforcement design.
Regulated supply and medicinal accessLicensed products or supervised services can support quality control and traceability. Compliance costs can exclude people, and commercial promotion may undermine public-health goals.

A practical public voice

Put a substance-specific proposal to state and federal representatives: which activity changes, for which adults, with which protections and how will outcomes be measured? Compare access, health harms, enforcement burden, equity and autonomy. This room offers policy choices and legal sources, not growing or production instructions.

Name the rule you want changed

A useful reform case identifies the substance, conduct and jurisdiction, then compares the exact provision, evidence of harm and proposed change. The Relevance Ladder and Australian Legal Engine support legal inquiry and source retrieval; they are not an adopted plant policy or a substitute for legal advice.

Status and sources

Checked 3 October 2026. Source dates and jurisdictions remain attached to the evidence. These are choices for public discussion, not an adopted party platform.

Compare international models without importing their law

Oregon’s psilocybin-services model uses licensed service centres and facilitators and sits alongside continuing US federal restrictions. It is a different framework from Australia’s authorised-psychiatrist pathway. Compare access, training, cost, adverse-event reporting and follow-up; a service framework elsewhere does not establish a right to grow or supply in Australia.

A question for the workbench

“Name the plant, name the harm, then justify the rule.”